Recent Articles

Can a routine vaccine prevent dementia?

Some adults may need a measles booster shot. Who should get one and why?

Less butter, more plant oils, longer life?

Healthier planet, healthier people

Counting steps is good — is combining steps and heart rate better?

Appendix pain: Could it be appendicitis?

Can saw palmetto treat an enlarged prostate?

How does Ozempic work? Understanding GLP-1s for diabetes, weight loss, and beyond

Zinc: What it does for the body, and the best food sources

Respiratory health harms often follow flooding: Taking these steps can help

Diseases & Conditions

Are the new migraine medications working?

October 1, 2019

Doctors say three recently approved migraine prevention drugs are helping people have fewer headaches.

For people with frequent, debilitating migraine headaches, 2018 brought encouraging news. The FDA approved three new medications — erenumab (Aimovig), fremanezumab (Ajovy), and galcanezumab (Emgality) — the first drugs designed specifically to prevent migraines and reduce their frequency, intensity, and duration.

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

Research health conditions
Check your symptoms
Prepare for a doctor's visit or test
Find the best treatments and procedures for you
Explore options for better nutrition and exercise

Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».

Share This Page

Print This Page

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.